Your English writing platform
Discover LudwigSuggestions(1)
Exact(2)
The morphology structure, especially the morphology rebuilding mechanism has been evaluated after being treated by these three schedules.
A randomised phase II study in colorectal cancer patients comparing these three schedules reported response rates of 24, 21 and 23%, respectively; all three schedules were generally well tolerated (Van Cutsem et al, 2000).
Similar(57)
These three scheduling access schemes assist to allocate slots to heterogeneous nature of a patient's data.
In these three scheduling schemes, the working nodes are chosen in completely a random method, which may result in the instability of the QoC.
We present these two schedules and provide a detailed example for each schedule.
In fact, any quality-price pair in the space contained between these two schedules would bring about positive profits.21 For lower efficiency A j, the cost schedule would shift upwards.
The majority of patients tolerated these two schedules well.
These two schedules (i.e. 1.5 4 6 and 1.5 6) were evaluated prospectively using the data of the validation group.
Recently published data from an open-label randomized phase II trial have demonstrated equal efficiency of these two schedules with the established 7-day schedule, 63 although overall survival was not a study endpoint.
24 These two schedules were significantly superior to the weekly schedule, with a better response rate (33% versus 16%, P ≤ 0.0001) and longer median time to progression (5.8 months versus 2.8 months, P = 0.0001).
Petit et al, 2001 have shown that FE100C was more effective than FE50C in the neoadjuvant setting in patients with HER2-positive disease, whereas for HER2-negative disease no difference between these two schedules could be observed.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com